BackBioethics, Overview

Bioethics, Total Liabilities

Track Bioethics,'s total liabilities ($950K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$945884.00
↑ 21.83% YoYΔ $169481.00 vs prior year quarter

Peer trimmed avg / median

Loading

Bioethics, Total Liabilities History

Loading

Bioethics, vs. peers: Total Liabilities Comparison

Loading

Bioethics, Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Bioethics, (BOTH) FAQ

As of the most recent data (December 2024), BOTH shows a total liabilities of $950K. That compares with $780K in the prior-year period — up 21.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BOTH's total liabilities is now $950K (was $780K) — a 21.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Bioethics, is outperforming or lagging.

Tracking BOTH's total liabilities over time shows whether Bioethics, is scaling, shrinking, or reshaping that part of the business. The current reading is $950K That compares with $780K in the prior-year period — up 21.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Bioethics,'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $950K) with ownership activity and broader fundamentals.